Obinutuzumab & Rituximab Safety Risks
HTML-код
- Опубликовано: 24 июл 2024
- An overview of the safety risks of patients with follicular lymphoma at high risk for early progression taking either obinutuzumab or rituximab.
For more resources and information regarding anticancer targeted therapies: targetedonc.com/